Interaction between natural compounds and human topoisomerase I

被引:42
|
作者
Castelli, Silvia [1 ]
Coletta, Andrea [1 ]
D'Annessa, Ilda [1 ]
Fiorani, Paola [2 ]
Tesauro, Cinzia [1 ]
Desideri, Alessandro [1 ]
机构
[1] Univ Roma Tor Vergata, Dept Biol, I-00133 Rome, Italy
[2] CNR, Natl Res Council, Inst Translat Pharmacol, I-00133 Rome, Italy
关键词
enzymatic catalytic steps; inhibition mechanism; natural compounds; topoisomerase I; CONJUGATED EICOSAPENTAENOIC ACID; DNA TOPOISOMERASE; CAMPTOTHECIN RESISTANCE; LEISHMANIA-DONOVANI; LUOTONIN-A; ANTITUMOR PROPERTIES; CYTOTOXIC ACTIVITY; SINGLE MUTATION; BETA-LAPACHONE; CANCER-CELLS;
D O I
10.1515/hsz-2012-0240
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Eukaryotic topoisomerase I (Top1) is a monomeric enzyme that catalyzes the relaxation of supercoiled DNA during important processes including DNA replication, transcription, recombination and chromosome condensation. Human Top1 I is of significant medical interest since it is the unique cellular target of camptothecin (CPT), a plant alkaloid that rapidly blocks both DNA and RNA synthesis. In this review, together with CPT, we point out the interaction between human Top1 and some natural compounds, such us terpenoids, flavonoids, stilbenes and fatty acids. The drugs can interact with the enzyme at different levels perturbing the binding, cleavage, rotation or religation processes. Here we focus on different assays that can be used to identify the catalytic step of the enzyme inhibited by different natural compounds.
引用
收藏
页码:1327 / 1340
页数:14
相关论文
共 50 条
  • [31] Fragment responsible for translocation in the N-terminal domain of human topoisomerase I
    Girstun, Agnieszka
    Kowalska-Loth, Barbara
    Czubaty, Aliqja
    Klocek, Magdalena
    Staron, Krzysztof
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2008, 366 (01) : 250 - 257
  • [32] Preclinical pharmacology of the natural product anticancer agent 10-hydroxycamptothecin, an inhibitor of topoisomerase I
    Ruiwen Zhang
    Yufeng Li
    Qiuyin Cai
    Tiepu Liu
    He Sun
    Brandon Chambless
    Cancer Chemotherapy and Pharmacology, 1998, 41 : 257 - 267
  • [33] Papillomavirus E2 protein interacts with and stimulates human topoisomerase I
    Clower, RV
    Hu, Y
    Melendy, T
    VIROLOGY, 2006, 348 (01) : 13 - 18
  • [34] Preclinical pharmacology of the natural product anticancer agent 10-hydroxycamptothecin, an inhibitor of topoisomerase I
    Zhang, RW
    Li, YF
    Cai, QY
    Liu, TP
    Sun, H
    Chambless, B
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1998, 41 (04) : 257 - 267
  • [35] In Silico and In Vitro Studies of Natural Compounds as Human CK2 Inhibitors
    Haidar, Samer
    Juergens, Franziska
    Eichele, Dagmar
    Jose, Joachim
    CURRENT COMPUTER-AIDED DRUG DESIGN, 2021, 17 (02) : 323 - 331
  • [36] The Association Between the p53/topoisomerase I and p53/topoisomerase IIα Immunophenotypes and the Progression of Ovarian Carcinomas
    Bar, Julia K.
    Grelewski, Piotr
    Noga, Leszek
    Rabczynski, Jerzy
    Grybos, Marian
    Jelen, Michal
    ADVANCES IN CLINICAL AND EXPERIMENTAL MEDICINE, 2012, 21 (01): : 35 - 42
  • [37] Enhanced topoisomerase I activity and increased topoisomerase IIα content in cisplatin-resistant cancer cell lines
    Minagawa, Y
    Kigawa, J
    Irie, T
    Kanamori, Y
    Itamochi, H
    Cheng, XS
    Terakawa, N
    JAPANESE JOURNAL OF CANCER RESEARCH, 1997, 88 (12): : 1218 - 1223
  • [38] Physical and functional interaction between D-ribokinase and topoisomerase I has opposite effects on their respective activity in Mycobacterium smegmatis and Mycobacterium tuberculosis
    Yang, Qiong
    Liu, Yuanyuan
    Huang, Feng
    He, Zheng-Guo
    ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 2011, 512 (02) : 135 - 142
  • [39] Cell-based high-throughput compound screening reveals functional interaction between oncofetal HMGA2 and topoisomerase I
    Peter, Sabrina
    Yu, Haojie
    Ivanyi-Nagy, Roland
    Droge, Peter
    NUCLEIC ACIDS RESEARCH, 2016, 44 (22)
  • [40] Benzimidazoles: Selective Inhibitors of Topoisomerase I with Differential Modes of Action
    Bonsal, Sandhya
    Sur, Souvik
    Tandon, Vibha
    BIOCHEMISTRY, 2019, 58 (06) : 809 - 817